Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Endosonics

This article was originally published in The Gray Sheet

Executive Summary

Endosonics: Gains FDA approval for its Oracle Megasonics family of combined percutaneous transluminal coronary angioplasty and ultrasound imaging catheters. Intended for use with Cordis' Duralyn high-pressure PTCA balloon, the Megasonics catheter line "demonstrates the strategic advantages of an all-electronic design compared with competitive mechanical approaches (ultrasound transducer on a spinning drive shaft) because it can both provide images of the lumen and artery wall as well as perform PTCA," Endosonics says. The catheter system will be marketed in the U.S., Canada and Europe through Cordis, which has a marketing and joint technology development deal with Endosonics...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT007098

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel